An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is reached in near 50% of patients with the previous m...

Full description

Bibliographic Details
Main Authors: Norberto C. Chávez-Tapia, Ezequiel Ridruejo, Angelo Alves de Mattos, Fernando Bessone, Jorge Daruich, Juan F. Sánchez-Ávila, Hugo Cheinquer, Rodrigo Zapata, Misael Uribe, Francisco Bosques-Padilla, Adrián Gadano, Alejandro Soza, Milagros Dávalos-Moscol, Claudio Marroni, Linda Muñoz-Espinoza, Graciela Castro-Narro, Raymundo Paraná, Nahum Méndez-Sánchez, MD, MSc, PhD, FACG, AGAF
Format: Article
Language:English
Published: Elsevier 2013-03-01
Series:Annals of Hepatology
Subjects:
Consensus
Therapeutics
Boceprevir
Liver diseases
Chronic hepatitis C
Telaprevir
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119314048

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119314048

Similar Items